Oncodona

Overview

What is Oncodona test?

Oncodona is the most advanced genetic test for early identification of predisposition to inherited cancer.
This test analyzes 21 genes related to breast and ovarian cancer in order to locate mutations that increase the risk of developing these types of cancer.
Oncodona uses Next Generation Sequencing (NGS) to analyze genetic information present in a panel of 21 genes, including BRCA1 and BRCA2 genes, in order to locate harmful mutations.

Features

Indications
Benefits

Is Oncodona for you?

This test is recommended if:

You’ve been diagnosed with breast cancer and BRCA1 and BRCA2 negative genetic test. Oncodona can find a mutation in up to 4% of women.
A woman in your family has been diagnosed with breast and ovarian cancer.
You just want to know if you have any risk of developing breast and ovarian cancer.

Why use Oncodona?

The performance of the test, if positive, can be used to adopt follow-up and personalized early detection measures of the patient and their relatives.
A negative result means that the patient does not have an increased risk. In other words, their risk of suffering one of the types of cancer analysed by the test is the baseline risk of the population.

How does it work?

What now?

[gravityform id=4 title=false description=false ajax=true tabindex=49]

Other services you may be interested

CGT

Carrier Genetic Test
Determines the risk of having a child with a genetic disease

More information

PGT-M

Plus d'informations

PGT-A

Improves the chances of reproductive success by selecting chromosomally normal embryos

More information

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

Early identification of predisposition to inherited cancer.

Results in 30 days.

Harmful mutations can be transmitted with a 50% probability.

What is Oncodona test?

Is Oncodona for you?

Why use Oncodona?

BROCHURE

Subscribe to
our newsletter

What now?

CGT

PGT-M

PGT-A

A complete test of genetic screening that analyzes 21 genes related to breast and ovarian cancer.

Early identification of predisposition to inherited cancer.

Results in 30 days.

Harmful mutations can be transmitted with a 50% probability.

What is Oncodona test?

Is Oncodona for you?

Why use Oncodona?

BROCHURE

Subscribe to our newsletter

What now?

Other services you may be interested

CGT

PGT-M

PGT-A

Igenomix is in the media

Subscribe to
our newsletter